- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Unresectable HER2-Negative Breast Carcinoma in Belgium
Total 159 results
-
KU LeuvenNovartisUnknownER Positive, HER2 Negative Breast Cancer NeoplasmsBelgium
-
Jules Bordet InstituteHoffmann-La RocheActive, not recruitingHER2-negative Breast Cancer | ER+ Breast Cancer | Invasive Lobular Breast CarcinomaFrance, Belgium
-
German Breast GroupGilead Sciences; ETOP IBCSG Partners Foundation; UNICANCER; Austrian Breast & Colorectal... and other collaboratorsActive, not recruitingTriple Negative Breast Cancer | HER2-negative Breast CancerFrance, Spain, Germany, Switzerland, Austria, Ireland, Belgium
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Olema Pharmaceuticals, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Korea, Republic of, Australia, Taiwan, Hong Kong, Malaysia, Thailand, Argentina, Belgium, Portugal, Italy, Czechia, Mexico, Poland, Germany
-
Jules Bordet InstituteCompletedBreast Neoplasms | Secondary | HER2 Positive Carcinoma of BreastBelgium
-
Jules Bordet InstituteRecruitingTNBC - Triple-Negative Breast CancerBelgium
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
Universitaire Ziekenhuizen KU LeuvenCompletedBreast Cancer | Triple Negative Breast Cancer | Hormone Receptor Negative NeoplasmBelgium
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
European Organisation for Research and Treatment...Breast International Group; Menarini GroupRecruitingStage IIB Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Stage III Breast CancerBelgium, Italy, Ireland, France, Germany
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
Pierre Fabre MedicamentIqvia Pty LtdRecruitingBreast Cancer | HER2-positive Breast Cancer | Adjuvant TherapyBelgium
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Finland, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, India, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Gua... and more
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Breast Cancer | Metastatic Triple Negative Breast CancerJapan, Belgium, France, Netherlands
-
Jules Bordet InstituteWithdrawnBreast CancerBelgium, France
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Grand Hôpital de CharleroiCliniques universitaires Saint-Luc- Université Catholique de LouvainCompletedBreast Cancer | Triple Negative Breast Cancer | Luminal BBelgium
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
AstraZenecaCompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerBelgium, Canada, Austria, Australia
-
AZ-VUBUniversitaire Ziekenhuizen KU Leuven; Universitair Ziekenhuis BrusselCompleted
-
SanofiTerminatedTriple Negative Breast CancerSpain, Belgium, Italy, Czechia, Netherlands
-
Lytix Biopharma ASICON plc; TheradexCompletedMelanoma | Lymphoma | Cancer | Breast Cancer | Head and Neck Cancer | Triple-Negative Breast CancerUnited Kingdom, France, Norway, Belgium, Italy
-
ERYtech PharmaTerminatedTriple Negative Breast CancerSpain, Belgium, Hungary
-
Cliniques universitaires Saint-Luc- Université...CompletedObservational Trial on the Impact of Hypnose Used as a Sedation in Oncology Surgery in Breast CancerEarly Stage Breast CarcinomaBelgium
-
Jules Bordet InstituteAstraZenecaActive, not recruitingTriple Negative Breast CancerFrance, Belgium
-
Jules Bordet InstituteCompletedCarcinoma Breast Stage IVBelgium
-
TransgeneMerck Sharp & Dohme LLC; BioInvent International ABRecruitingMelanoma | Soft Tissue Sarcoma | Non Small Cell Lung Cancer | Metastatic Cancer | Triple Negative Breast Cancer | Merkel Cell CarcinomaFrance, Belgium
-
Eli Lilly and CompanyTerminatedRenal Cell Carcinoma | Solid Tumor | Non Small Cell Lung Cancer | Triple Negative Breast CancerBelgium, Spain, United States, France, Italy, Denmark
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
SanofiCompletedBreast Cancer, MetastaticAustralia, Belgium, France, Italy, Netherlands, Spain
-
MedImmune LLCCompletedHormone-sensitive, HER-2 Negative Metastatic Breast CancerSpain, United States, Belgium, France, United Kingdom, Canada, Israel, Germany, Hungary, Poland, Bahamas
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
XEOS MedicalRecruitingBreast Cancer | Breast Cancer Invasive | Breast Cancer in SituBelgium
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Zenith EpigeneticsPfizer; Newsoara Biopharma Co., Ltd.TerminatedTriple Negative Breast CancerUnited States, Belgium, China, Spain
-
Universitaire Ziekenhuizen KU LeuvenEli Lilly and Company; Kom Op Tegen Kanker; Teva PharmaRecruitingTriple Negative Breast NeoplasmsBelgium
-
Nektar TherapeuticsBristol-Myers SquibbCompletedMelanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Urothelial Carcinoma | HR+/HER2- Breast CancerUnited States, Spain, Canada, France, Italy, Belgium, Poland, United Kingdom
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
University Hospital, GhentCompleted
-
AstraZenecaCompletedPancreatic Ductal Adenocarcinoma | Triple-negative Breast Cancer | Urothelial Bladder CancerUnited States, Belgium, Korea, Republic of, Poland, Netherlands
-
Jules Bordet InstituteGlaxoSmithKline; Schering-PloughCompletedMetastatic Breast Cancer | Brain Metastases | HER2 PositiveBelgium
-
Université Catholique de LouvainAnticancer Fund, BelgiumCompletedCurative Breast Cancer Surgery | Inflammatory Positive/Negative Status | Pre Surgical Incision AdministrationBelgium
-
Hoffmann-La RocheCompletedTriple-negative Breast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Belgium, Brazil, Germany, Taiwan, Australia, Japan, Spain, Poland, Italy
-
Ayala Pharmaceuticals, Inc,TerminatedTriple Negative Breast CancerUnited States, Belgium, Israel, Spain, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingAdvanced HER2+Breast CancerBelgium, France, China, Italy, Spain, Malaysia, United States, Turkey
-
Novartis PharmaceuticalsCompletedColorectal Cancer, Triple Negative Breast Cancer, NSCLC - AdenocarcinomaUnited States, France, Taiwan, Canada, Italy, Singapore, Belgium, Spain, Israel
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more